WoS Publication RDF
pages:- 208
- 209
- 210
- 211
- 212
- 213
- 214
- 215
- 216
- 217
- 218
- 219
- 220
- 221
- 222
- 223
- 224
- 225
- 226
- 227
- 228
- 229
- 230
- 231
- 232
- 233
- 234
- 235
- 236
- 237
- 238
- 239
- 240
- 241
- 242
- 243
- 244
- 245
- 246
- 247
- 248
- more...
- Safety and benefit considerations for menopausal hormone therapy Review
- Safety and Effectiveness of a Bioabsorbable Steroid-Releasing Implant for the Paranasal Sinus Ostia A Randomized Clinical Trial Article
- Safety and effectiveness of the TREO stent graft for the endovascular treatment of abdominal aortic aneurysms Article
- Safety and efficacy of amniotic cytokine extract in the treatment of dry eye disease Article
- Safety and efficacy of bimekizumab through 2 years in patients with moderate to severe plaque psoriasis: Long-term results from BE SURE randomised controlled trial and BE BRIGHT open-label extension Meeting Abstract
- Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trial Article
- Safety and Efficacy of Collagenase Clostridium histolyticum in the Treatment of Acute Phase Peyronie's Disease: A Multi-institutional Analysis Article
- Safety and efficacy of Implanon (TM), a single-rod implantable contraceptive containing etonogestrel Article
- Safety and efficacy of intratracheal recombinant human Clara cell protein in a newborn piglet model of acute lung injury. Article
- Safety and efficacy of intravitreal bevacizumab followed by pegaptanib maintenance as a treatment regimen for age-related macular degeneration. Article
- Safety and Efficacy of Lanreotide Depot Versus Placebo in Neuroendocrine Tumor Patients With a History of Carcinoid Syndrome and Prior Octreotide Therapy Meeting Abstract
- SAFETY AND EFFICACY OF LANREOTIDE DEPOT VS PLACEBO IN NEUROENDOCRINE TUMOR PATIENTS WITH A HISTORY OF CARCINOID SYNDROME AND PRIOR OCTREOTIDE THERAPY. Meeting Abstract
- SAFETY AND EFFICACY OF MCC-257 IN DIABETIC PERIPHERAL NEUROPATHY: RESULTS OF A MULTICENTER RANDOMIZED PLACEBO-CONTROLLED CLINICAL TRIAL AND OPEN-LABEL EXTENSION Meeting Abstract
- Safety and Efficacy of Moderate-dose Denosumab in Fibrous Dysplasia: Observational Results From a Phase 2 Clinical Trial Article
- Safety and Efficacy of WC2031 Versus Vibramycin for the Treatment of Uncomplicated Urogenital Chlamydia trachomatis Infection: A Randomized, Double-blind, Double-Dummy, Active-Controlled, Multicenter Trial Article
- SAFETY AND EFFICACY OF WC2031 VS VIBRAMYCIN FOR THE TREATMENT OF UNCOMPLICATED UROGENITAL CHLAMYDIA TRACHOMATIS INFECTION Meeting Abstract
- Safety and efficacy results for the segesterone acetate ethinyl estradiol (SA/EE) contraceptive vaginal ring Meeting Abstract
- Safety and Pharmacokinetics of a Tenofovir Alafenamide Fumarate-Emtricitabine based Oral Antiretroviral Regimen for Prevention of HIV Acquisition in Women: A Randomized Controlled Trial Article
- Safety and tolerability of a new low-dose contraceptive patch in obese and nonobese women Article
- Safety and Tolerability of Bazedoxifene/Conjugated Estrogens in Postmenopausal Women: Findings From a 1-Year, Randomized, Placebo- and Active-controlled, Phase 3 Trial Meeting Abstract
- Safety and Tolerability of Lanreotide Autogel/Depot (LAN) in Patients (pts) with Neuroendocrine Tumours (NETs): Pooled Analysis of Clinical Studies Meeting Abstract
- Safety and Tolerability of Lanreotide Autogel/Depot in Patients With Neuroendocrine Tumors: Pooled Analysis of Clinical Studies Meeting Abstract
- SAFETY AND TOLERABILITY OF THE AGILE PATCH, A CONTRACEPTIVE PATCH WITH LOW-DOSE ETHINYL ESTRADIOL (EE) AND LEVONORGESTREL (LNG), VS. COMBINATION ORAL CONTRACEPTIVES (COCS) IN OBESE VS. NON-OBESE WOMEN Meeting Abstract
- Safety evaluation of 1% tenofovir gel in healthy men Article
- Safety of fenbendazole in common peafowl (Pavo cristatus). Article
- Safety of Oral Ospemifene in Phase 2/3 Placebo-controlled Clinical Trials Meeting Abstract
- Safety of paliperidone extended-release in patients with schizophrenia or schizoaffective disorder and hepatic disease.
- Safety profile of two novel antiepileptic agents approved for the treatment of refractory partial seizures: ezogabine (retigabine) and perampanel Review
- Safety testing of Ovaprene: An investigational nonhormonal monthly vaginal contraceptive Article
- Salvage Surgery for Locoregional Failure after Chemoradiation in Rectal Squamous Cell Carcinoma: A National Cancer Database Analysis Meeting Abstract